| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > ISO 9000 Elements |
|
Advice You - ISO 9000 Elements
ISO 9000 is a set of standards for quality management systems. Perhaps, it is the most popular gen According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product eric international standard today. First published in 1987 and modified in 1994, it is the true ba ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in sis for businesses to develop or improve their quality assurance systems. Today, most internationa lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. businesses document their quality systems according to the ISO 9001 elements. There are a total here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe of 20 elements (sections) in the overall ISO 9000 standard. Each section explains what a company h d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s to do in order to show that it is abiding by the ISO 9000 rules. Each of these elements should b ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc e clearly and completely documented. The twenty ISO 9000 elements include management responsibili easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ty, quality management system (QMS), contract review, design control, document control, purchasing nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically purchaser supplied product, process control, inspection and testing, inspection, measuring and te and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ st equipment, inspection and test status, control of non-conforming product, corrective action, ha ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi dling, storage, packaging and delivery, control of quality records, internal quality audits, train ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ing, servicing, and statistical techniques and product ID and traceability. Management responsibi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod lity addresses the responsibility of an organization to set up a system that frequently meets cons cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin mer requirements and expectations, even in times of managerial change. Quality management system d tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen efines general requirements, along with documentation requirements such as quality manual, procedu t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel es, work instructions and records. Design control requires that all phases in the designing of pr ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust oducts or services must be managed and conducted by qualified employees. The ISO element document y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products control requires that all documents and data used must be controlled and authorized. The section . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de f statistical techniques includes data analysis, sampling methods, and SPC (statistical process co elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ntrol). These processes should be based on established procedures and sound statistical techniques tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:New Requirement for NSAs - Background Check
|